The Oncology Institute's revenue for the
three
months ended in Mar. 2024 was $94.7 Mil.
Its revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $342.7 Mil.
The Oncology Institute's Revenue per Share for the
three
months ended in Mar. 2024 was $1.28.
Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $4.63.
During the past 12 months, the average Revenue per Share Growth Rate of The Oncology Institute was 34.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 14.80% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 16.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 6 years, The Oncology Institute's highest 3-Year average Revenue per Share Growth Rate was 20.40% per year. The lowest was 9.10% per year. And the median was 14.80% per year.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of The Oncology Institute's Revenue
For the Medical Care Facilities subindustry, The Oncology Institute's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Oncology Institute's Revenue Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, The Oncology Institute's Revenue distribution charts can be found below:
* The bar in red indicates where The Oncology Institute's Revenue falls into.
The Oncology Institute Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $342.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Oncology Institute (NAS:TOI) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
The Oncology Institute Revenue Related Terms
Thank you for viewing the detailed overview of The Oncology Institute's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
The Oncology Institute (The Oncology Institute) Business Description
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TOI has been successfully added to your 